What is ADMA Biologics's net income?

ADMA Biologics (ADMA) reported net income of $45.33M in Q1 2026.

How has ADMA Biologics's net income changed year-over-year?

ADMA Biologics's net income increased by 68.5% year-over-year, from $26.9M to $45.33M.

What is the long-term trend for ADMA Biologics's net income?

Over 4 years (2021 to 2025), ADMA Biologics's net income has grown at a 19.7% compound annual growth rate (CAGR), from -$71.65M to $146.93M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

ADMA Biologics ADMA Net Income

Net Income at other companies

AbCellera Biologics Inc.ABCL

-$43.17M+5.4%

AnaptysBio, Inc.ANAB

-$52.88M-34.5%

ZymeworksZYME

-$44.16M-95.1%

Apogee Therapeutics, Inc.APGE

-$74.11M-33.9%

Quest DiagnosticsDGX

$252M+14.5%

BiohavenBHVN

-$130.53M+41.1%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's net income?: ADMA Biologics (ADMA) reported net income of $45.33M in Q1 2026.
How has ADMA Biologics's net income changed year-over-year?: ADMA Biologics's net income increased by 68.5% year-over-year, from $26.9M to $45.33M.
What is the long-term trend for ADMA Biologics's net income?: Over 4 years (2021 to 2025), ADMA Biologics's net income has grown at a 19.7% compound annual growth rate (CAGR), from -$71.65M to $146.93M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.